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Hair follicle formation and maintenance involve
intimate interactions between follicular epithelial
cells and a group of specialized mesenchymal cells
known as the dermal papilla. Using the random pri-
mer polymerase chain reaction, we have identi®ed
an »1.4 kb osteopontin mRNA that is present in
large quantities in cultured rat vibrissa dermal papilla
cells but undetectable in cultured rat skin ®broblasts.
In situ hybridization showed that the osteopontin
gene is expressed in dermal papilla cells of pelage
follicles during catagen but not in anagen or telogen.
As an acidic glycosylated RGD-containing extracel-
lular matrix protein, osteopontin can function both
as a cell attachment protein and as a soluble cytokine
playing roles in signaling, cell migration, tissue sur-
vival, anti-in¯ammation, and T-cell-mediated cellu-
lar immunity. Our results indicate that the
comparison of the mRNA of cultured dermal papilla
cells and ®broblasts can lead to the identi®cation of
not only anagen-speci®c genes (e.g., nexin 1), but
also a catagen-speci®c gene. We have thus provided
evidence that speci®c genes are turned on during
catagen, which is therefore not simply a passive
``degenerative'' phase. The functional role of osteo-
pontin in catagen is unclear but it may promote the
formation of a tightly aggregated dermal papilla,
and/or protect the dermal papilla cells from apopto-
sis induced by cytokines or hypoxia during catagen.
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T
he interactions between dermal papilla, a group of
hair-follicle-speci®c mesenchymal cells, and follicular
epithelial cells play an important role in the regulation
of hair follicle development and cyclic growth (Stenn
and Paus, 2001). The speci®city of the mesenchymal
signal has been well established by early hair reconstitution studies
showing that dermal papilla, but not skin ®broblasts, can rescue
follicles devoid of the lower one third of the follicle (Oliver, 1970;
Jahoda and Oliver, 1984). The diameter and length of the hair ®ber
are directly proportional to the volume and cell number of the
dermal papilla (Van Scott and Ekel, 1958; Elliott et al, 1999). The
androgen receptor and 5-a reductase levels of dermal papilla cells
are variable and seem to play a role in androgen-dependent hair
growth and androgenic alopecia (Randall et al, 1993, 1996;
Thornton et al, 1996, 2001; Obana et al, 1997; Eicheler et al,
1998; Hibberts et al, 1998). Thus dermal papilla cells clearly play a
key role in a number of important biologic processes including cell
differentiation, apoptosis, hormonal regulation of cell growth, and
mesenchymal±epithelial interaction.
Cells of the dermal papilla undergo striking morphologic changes
as the hair follicle progresses though different phases of the hair
cycle (Couchman, 1986; Messenger et al, 1991; Lavker et al, 1999).
Thus, dermal papilla cells of the hair follicles that are in the growing
phase (anagen) of the hair cycle are largely enclosed by follicular
matrix keratinocytes. At this stage, dermal papilla cells are
®broblastic in shape, are widely interspersed by large amounts of
extracellular matrix, and are supported by blood vessels. When the
follicle enters into the degenerative (catagen) phase of the hair
cycle, the extracellular matrix of the dermal papilla is markedly
diminished, and the cells become rounded and tightly packed with
greatly reduced intercellular space. In such catagen follicles, the
dermal papilla is encased by a ®brous connective tissue sheath that
undergoes contraction resulting in the retraction and upward
movement of the condensed dermal papilla, which eventually abuts
the lower end of the permanent portion of the resting (telogen) hair
follicle (Breathnach and Smith, 1968; Sugiyama et al, 1976; Muller-
Rover et al, 2001).
To better understand how the dermal papilla cells function in
regulating the hair cycle and in mediating hair diseases such as
androgenic alopecia, we sought to identify genes that distinguish
dermal papilla cells from their closely related skin ®broblasts. Using
the arbitrarily primed polymerase chain reaction (PCR) approach
(Liang and Pardee, 1992; 1997), we have previously shown that
nexin-1, a potent serine protease inhibitor, is abundantly expressed
in cultured rat vibrissa dermal papilla cells, but not in similarly
cultured skin ®broblasts (Yu et al, 1995; Sonoda et al, 1999). In situ
hybridization showed that nexin-1 is expressed by dermal papilla of
rat and human pelage hair follicles during anagen, but not during
catagen or telogen (Yu et al, 1995; Jensen et al, 2000). In this paper,
we describe the identi®cation of another molecule, osteopontin
(OPN), whose mRNA is accumulated in cultured rat vibrissa
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dermal papilla cells but not in cultured skin ®broblasts.
Interestingly, unlike nexin-1, which is limited to anagen follicles,
OPN is expressed only during catagen. These results indicate that
our approach of comparing cultured dermal papilla cells and skin
®broblasts allows for the identi®cation of hair-cycle-dependent
genes, and that OPN plays a role during the catagen phase of the
hair cycle.
MATERIALS AND METHODS
Cell culture Vibrissa follicles were dissected individually from the lip
region of (4±6-mo-old) Wistar rats, and their papillae were squeezed out
using a pair of forceps. The isolated papillae were placed in a small
amount of Chang's medium (1.5 ml per 60 mm) and left undisturbed in
a 37°C incubator (5% CO2) for 4 d. Under these conditions most of the
papillae formed outgrowths (Jahoda and Oliver, 1981; Warren et al,
1992). Ten to 12 d later the cells were treated with 0.1% trypsin and
0.05% ethylenediamine tetraacetic acid in phosphate-buffered saline, and
the dissociated single cells were then plated in Dulbecco's minimal
essential medium containing 10% fetal bovine serum. The lip skin tissues,
from which the vibrissae had been removed, were then minced
thoroughly to less than 1 mm3 and placed under outgrowth conditions
and subcultured as described above. When grown under these
conditions, the papillary cells and skin ®broblasts maintained distinct
morphology (Jahoda and Oliver, 1984). The RNA of the cultured cells
(three to four passages) were extracted in 4 M guanidinium thiocyanate,
puri®ed by ultracentrifugation, and treated with RNase-free bovine
pancreatic DNase (Chomczynski and Sacchi, 1987).
Differential display of mRNA Total RNA of cultured cells were
reverse transcribed and subjected to PCR using 20 3¢-oligo(dT)12
primers (14 bp) coupled with 20 5¢-random primers (10 bp
oligodeoxynucleotides) (Liang and Pardee, 1992). After the PCR, the
cDNAs were resolved on a 6% polyacrylamide DNA sequencing gel.
The area of a dried gel containing a cDNA fragment of interest was
excised and extracted by heating in distilled water at 90°C for 5 min.
Figure 1. Identi®cation and ampli®cation of a dermal-papilla-
speci®c cDNA. Total RNA (0.2 mg) isolated from cultured rat vibrissa
papillary (p) cells and skin ®broblasts (F) were mixed with a speci®c 3¢-
oligo-(dT) primer, reverse transcribed, mixed with a 5¢-``arbitrary''
primer, and ampli®ed by PCR. The resultant partial cDNAs were
resolved electrophoretically on a DNA-sequencing polyacrylamide gel,
and the partial cDNA patterns of two independent batches of cultured
®broblasts (lanes 1, 2) and dermal papilla cells (lanes 3, 4) generated using
a particular pair of primers are shown here. Note that the two cell types
shared most cDNA species, except a prominent band of 315 bp unique
to the dermal papilla cells. Lanes 5 and 6 show the patterns of ®broblasts
and dermal papilla cells, respectively, in another independent experiment.
This 315 bp band was excised and used as a template to generate a re-
ampli®cation product (marked by arrow in lane 7).
Figure 2. The 315 bp partial cDNA encodes OPN. The
deoxynucleotide sequence of the 315 bp cDNA clone is shown in bold,
corresponding to bases 847±1162 of a published rat OPN cDNA
sequence (Giachelli et al, 1993). The 5¢- and 3¢-oligodeoxynucleotide
primers used for reverse transcription PCR are indicated, with vertical
lines showing identities between the primers and the OPN sequence.
Figure 3. Follicular speci®city of the OPN message as shown by
northern blotting. Total RNA (20 mg) of cultured human embryonic
lung ®broblasts (lane 1; HF), rat skin ®broblasts (lane 2; F), and rat
vibrissa papillary cells (lane 3; p) were resolved electrophoretically on a
formaldehyde-agarose gel, and probed with a 32P-labeled 315 bp partial
OPN cDNA (a), a full-length 1.4 kb OPN cDNA (b), or actin cDNA
(a¢, b¢). Numbers on the right of panel (b) denote the size markers in
kilobases (kb). Note that although the three cell types contained about
equal amounts of actin message, a prominent »1.4 kb OPN mRNA
(arrow) was detected as a major component only in the follicular dermal
papilla cells.
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The solubilized partial cDNA was used as the template for two rounds of
re-ampli®cation using the original pair of primers. After the size of the
re-ampli®ed cDNA fragment was con®rmed by gel electrophoresis, the
fragment was cloned into a PCRII vector and sequenced using the
dideoxynucleotide procedure of Singer (US Biochemical Kit). Northern
blot analysis and in situ hybridization were performed according to
previously described procedures (Yu et al, 1995; Jensen et al, 2000).
Virtual northern analyses The cDNAs of cultured rat vibrissa dermal
papilla cells and ®broblasts were synthesized using a SMART PCR
cDNA synthesis kit (Clontech, Palo Alto, CA). The ampli®cation of
such cDNAs by PCR was done for 17 cycles, whereas the increase in
the amounts of two major mRNA species (glyceraldehyde-3-phosphate
dehydrogenase and tubulin) was still in a linear range. The same amounts
of total DNA from each sample were then analyzed by southern blot.
RESULTS AND DISCUSSION
Using 20 5¢-random PCR primers coupled with the same number
of 3¢-primers, we performed »400 PCR using the cDNAs of
cultured rat vibrissa dermal papilla cells and skin ®broblasts as the
templates. Electrophoretic comparison of the cDNAs revealed a
partial cDNA of 315 bp that was abundant in cultured dermal
papilla cells but virtually undetectable in cultured ®broblasts
(Fig 1). This partial cDNA encoded OPN (Fig 2), a widely
distributed extracellular matrix protein that can be both glycosy-
lated and phosphorylated (see below). Northern blot analysis using
this 315 bp partial cDNA and a 1.4 kb full-length OPN cDNA
con®rmed the marked overexpression of this gene in cultured
Figure 4. Inhibition of OPN expression in cultured rat vibrissa
dermal papilla (p) cells by R1881, an androgen analog. Rat vibrissa
dermal papilla cells (p) and ®broblasts (F) were grown in Dulbecco's
minimum essential medium containing 10% fetal bovine serum. Half of
the dishes were fed with the same medium containing 10 nM R1881
(+), and the other half were maintained in a regular medium (±) for 3 d
postcon¯uence. Total RNA were extracted 3 d later from these cells and
the amounts of OPN and glyceraldehyde-3-phosphate dehydrogenase
were quanti®ed by (a)virtual northern analyses or by (b) regular northern
analyses. The numbers (A±/A+) indicate the ratio of OPN in regular
and R1881-containing media. Panel (b) shows the results of two
independent batches of vibrissa cells. Note the suppression of OPN
expression in cultured dermal papilla cells.
Figure 5. Expression of OPN in dermal
papillae of rat catagen hair follicles.
Specimens of skin were taken from rats that were
(a) 22 d old showing a telogen follicle ± note the
strong OPN signals in macrophages (asterisk) and
the lack of signals in the follicle; (b) 33 d old
showing an anagen hair follicle ± note the absence
of OPN signals; (c) 46 d old showing a catagen-III
follicle ± note strong OPN signals in the partially
condensed dermal papilla; (d, e) 46 d old showing
two catagen-IV follicles ± note strong OPN
signals in the condensed dermal papilla and the
newly formed trailing connective tissue sheath
(labeled C); (f) 45 d old catagen VII ± note strong
OPN signals in dermal papilla and trailing
connective sheath; and (g) 48 d old catagen III.
(a)±(g) Hematoxylin and eosin staining; (a¢)-(g¢)
dark ®eld pictures of the corresponding ®elds
highlighting the silver grain signals of OPN.
Abbreviations: p, dermal papilla cells; C, trailing
connective tissue sheath; *, macrophage. The
phases of hair cycle were designated according to
Muller-Rover et al (2001). Note the accumulation
of OPN mRNA in macrophages as well as in the
dermal papillary and trailing connective tissue
sheath cells of the catagen follicles, and the lack of
OPN expression in anagen follicles. Scale bar:
100 mm.
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dermal papilla cells (versus cultured skin ®broblasts; Fig 3).
Consistent with a previous report that androgen can suppress
OPN expression in medullary carcinoma (Nagoshi et al, 1994), we
found that the expression of OPN in cultured rat vibrissa dermal
papilla cells could also be suppressed by R1881, an androgen analog
(Fig 4).
We then analyzed the expression of OPN during different phases
of the hair cycle using in situ hybridization (Fig 5). OPN mRNA
was accumulated in the dermal papilla and the ``trailing connective
sheath'' of a subpopulation of rat pelage follicles that were in the
catagen phase of the hair cycle (Fig 5c±g, c¢±g¢). No OPN was
detected in the dermal papilla of the anagen (Fig 5b, b¢) or telogen
follicles (Fig 5a). Macrophages scattered around the pelage follicles
contained, as expected, abundant OPN messages (Fig 5a, a¢)
(Hirota et al, 1993; O'Brien et al, 1994). Very little OPN mRNA
was detected, however, in the nonfollicular dermal ®broblasts
(Fig 5), thus con®rming the dermal papilla ``speci®city'' of the
OPN gene.
Our approach of comparing the gene expression patterns of
cultured dermal papilla cells and ®broblasts has two potential
limitations. First, as cultured dermal papilla cells may mimic more
closely the presumably more metabolically active cells of the anagen
follicle, this approach may be limited to uncovering only those
genes, such as nexin-1, that are expressed during anagen (Yu et al,
1995). Second, as vibrissae differ from the pelage hairs in many of
their biologic features (Jahoda, 1992), the vibrissa genes we
identi®ed this way may not be expressed in the pelage hair. Our
results indicate, however, that our approach can lead to the
identi®cation of dermal-papilla-related genes that are expressed
during anagen as well as catagen phases of the pelage follicle.
OPN is a secreted protein with a predicted protein core
molecular weight of 52 kDa that can be both glycosylated and
phosphorylated (Denhardt et al, 2001a, b). The protein is frequently
overexpressed in transformed cells (Denhardt and Guo, 1993;
Rodan, 1995). Its expression is relatively tissue-speci®c and can be
regulated by a number of hormones, growth factors, tumor
promoters, and oncogenes. As the protein has an RGD domain,
many cell types, including osteoblasts, osteoclasts, and transformed
®broblasts, can bind OPN via the avb3 integrin receptor. An
interesting feature is that thrombin can cleave OPN close to the
RGD sequence, thus exposing the RGD site and enhancing
cellular binding (Senger et al, 1994). Another highly unusual feature
of OPN is that osteoclasts can bind only to phosphorylated OPN,
and that the cells can secrete a phosphatase to self-regulate their
interactions with the matrix (Ek-Rylander et al, 1994). Thus OPN
plays diverse roles in mediating cell±matrix interaction, growth
regulation, and various aspects of the in¯ammation/tissue repair
cascade (Denhardt and Guo, 1993; Rodan, 1995; Denhardt et al,
2001a, b). Our study provides the ®rst evidence that OPN may also
play a role in hair physiology.
The mechanism for the upregulation of the OPN gene in dermal
papilla of catagen follicles is unclear. Either the gene is activated
intrinsically in response to a set of catagen-speci®c transcription
factors, or it is secondarily induced by extracellular signals including
cytokines (Denhardt and Guo, 1993; Rodan, 1995), extracellular
matrix changes (Carvalho et al, 1998), or oxidants (Ramos, 1999)
that are known to induce the OPN gene.
Although the functional role of OPN in hair regulation is not yet
known, it may be involved in three aspects of hair growth. As
indicated earlier, we have previously demonstrated that the dermal
papilla cells of growing follicles express a high level of nexin-1
mRNA, which encodes a potent inhibitor of serine proteases
including thrombin (Yu et al, 1995; Sonoda et al, 1999; Jensen et al,
2000). The cessation of nexin-1 expression at the end of the
growing phase may allow protease activation of OPN, thus
enhancing the attachment of dermal papilla cells to OPN and
facilitating the aggregation of dermal papilla. Another possible
function of OPN in hair regulation relates to its ability to inhibit
in¯ammatory mediator-induced expression of the NO synthetase
gene and the production of nitric oxide (Rollo et al, 1996; Scott et
al, 1998). This may promote the survival of cells exposed to
hypoxia (Denhardt et al, 1995; Denhardt and Noda, 1998). Such a
protective effect of OPN suggests several potential roles. For
example, OPN may protect dermal papilla cells from the cytotoxic
effects of nitric oxide, which can be produced by macrophages
(Fig 4a, a¢), during catagen at a time of widespread cell destruction
and deprived blood supply (Dippel et al, 1994; Feng et al, 1995).
The putative protective function of OPN provides a possible
mechanism of androgenic alopecia (Schilli et al, 1998). We showed
that androgen can suppress OPN expression in cultured rat vibrissa
dermal papilla cells (Fig 4; Nagoshi et al, 1994). If such androgen
suppression of OPN expression also occurs in human scalp follicles,
this could compromise the protective function, thus resulting in a
loss of dermal papilla cells. Yet another recently described function
of OPN has to do with cellular immunity. The sensitization phase
of experimentally induced contact hypersensitivity is hair cycle
dependent (i.e., sensitization during anagen fails to elicit ear
swelling whereas sensitization during telogen results in marked ear
swelling). This observation suggests a hair-cycle-dependent mech-
anism whereby only an anagen follicle can produce immunosup-
pressive factors thus leading to a temporary state of
unresponsiveness to a hapten, i.e. the follicle becomes immune
privileged (Paus et al, 1999, and references therein). OPN has
recently been shown to upregulate interleukin-12 and suppress
interleukin-10 activity, making it an early component of type-1
immunity (Ashkar et al, 2000). Thus, OPN secreted by dermal
papilla during catagen may be able to trigger a type 1 immune
response mediated by effector cytokines such as interferon-g in
conjunction with a dampening of antiapoptotic factors (e.g.,
interleukin-4), resulting in the destruction of the lower portion of
the follicle. Additional studies are needed to test these several
possibilities.
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